Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock

NCT06351150 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

214

Enrollment

INDUSTRY

Sponsor class

Conditions

Vasodilatory Shock

Interventions

DRUG: Angiotensin II Injection
DRUG: 0.9% sodium chloride injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.